Dr Pratz is a clinical investigator of novel therapeutics for acute leukemias and is an Associate Professor of Medicine and Director of Leukemia Program at the Abramson Comprehensive Cancer Center at University of Pennsylvania. His work includes clinical trials incorporating novel targeted therapies into combinational chemotherapy in acute leukemia including studies of agents targeting BCL-2, FLT3, IDH, PARP, and CD47.